Overview

Clinical Trial of the ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Recurrent Brain Tumors

Status:
Recruiting
Trial end date:
2029-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test WSD0628 in combination with radiation therapy for recurrent brain tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Cancer Institute (NCI)